Non-executive director Guo Huaqing increased his holdings of CARSGEN-B (02171) by 70,000 shares, with a price of 14.8 Hong Kong dollars per share.
On November 6th, non-executive director Guo Huaqing increased his holdings of SciClone Pharmaceuticals-B stocks (02171) by 70,000 shares, at a price of 14.8 Hong Kong dollars per share, for a total amount of 1.036 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 6, non-executive director Guo Huaqing increased his holdings of CARSGEN-B (02171) by 70,000 shares, with a price of 14.8 Hong Kong dollars per share, totaling 1.036 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 218 million shares, with a shareholding ratio of 37.72%.
Related Articles
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
IDREAMSKY (01119) granted 10,948,500 stock options.
KN Hospital(02120) spent about 944,100 Hong Kong dollars to repurchase 82,100 shares on November 7th.
WEIYE HOLDINGS (01570) recommends changing the auditor.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
